Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants, Vincent Brichard, Brigitte Dr�no, Marie-H�l�ne Tessier, Elaine M. Rankin, Giorgio Parmiani, Flavio Arienti, Yves Humblet, A Bourlond, R Vanwijck, Danielle Li�nard, M. Beauduin, Pierre‐Yves Dietrich, Vincenzo Russo, Joseph Kerger, Giuseppe Masucci, Elke J�ger, Jacques De Grève, Jens Atzpodien, Francis Brasseur, Pierre G. Coulie, Pierre van der Bruggen, Thierry Boon

International Journal of Cancer, 1999

Ludwig Cancer Research, Cliniques Universitaires Saint-Luc, UCLouvain, Centre Hospitalier Universitaire de Nantes, The Netherlands Cancer Institute, Fondazione IRCCS Istituto Nazionale dei Tumori, Ludwig Cancer Research, University Hospital of Lausanne, Hôpital de Jolimont, Hôpital Beau-Séjour, The San Raffaele Telethon Institute for Gene Therapy, Université Libre de Bruxelles, Institut Jules Bordet, Sophiahemmet Hospital, Karolinska Institutet, Krankenhaus Nordwest, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Medizinische Hochschule Hannover

Publisher Website

Abstract

This research paper explore the methodology and findings associated with International Journal of Cancer. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

786

Citations

View on Google Scholar

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Abstract

Journal Details

Join JournalsHub

Welcome Back